Format : 18 videos + 1 pdf, size: 5.1 GB
UCLA Heart Failure Symposium 2023 Heart failure affects approximately six million Americans and is the most common diagnosis for acute hospitalization in patients over 65 years. Over the next decade, we will see a dramatic increase in the number of patients in the community with advanced heart failure who can benefit from advanced therapies for complex cardiac disease.
Academic medical centers, such as UCLA, have an opportunity to integrate treatment advances into a comprehensive patient-centered heart failure management program. UCLA Health wants to enhance the role of the primary care physician and primary cardiologist as the central provider for continuity of care for these complex heart failure patients.
The 11th Annual UCLA Heart Failure Symposium 2023 will:
- Discuss general heart failure treatment options including short and long term mechanical circulatory support therapy, heart transplantation, pulmonary hypertension management, high risk percutaneous and structural interventions, and complex congenital heart disease management.
- Emphasize the need for developing networks linking academic centers with community physicians to manage these patients through the evolution of their disease pre and post advanced cardiac intervention.
- Discuss heart failure therapies in cardio-oncology, amyloidosis and new medication updates, as well as address patient and care-provider’s specific needs and perspectives.
TARGET AUDEINCE
Family practitioners, internists, cardiologists, pediatricians, nurses and all other healthcare professionals taking care of heart failure patients, as well as the interested lay public.
LEARNING OBJECTIVES
At the conclusion of the program participants will be able to:
- Identify the epidemiology and pathophysiology of heart failure and the need for mechanical circulatory support with a growing heart failure population.
- Identify indications for and management of lifelong left ventricular assist device therapy.
- Implement shared care programs with the community and co-manage patients in need of complex cardiac therapies including LVAD therapy, heart transplantation, pulmonary hypertension management, high risk percutaneous interventions, and complex congenital heart disease management.
- Discuss the comprehensive multidisciplinary care and services available to complex cardiac patients within the UCLA Heart Failure Program.
+ Topics:
- heart_failure_2023h.pdf
A New Era of Organ Preservation and Procurement in Heart Transplantation Going the Distance.mp4
A Road to Recovery Cardiac Rehabilitation in CardiomyopathyA Road to Recovery Cardiac Rehabilitation in Cardiomyopathy.mp4
Adult Congenital Heart Disease Novel Therapeutics and Interventions.mp4
Aortic Stenosis in Heart Failure Patients When to Consider TAVR .mp4
Breakthroughs in Heart Failure Therapies and Digital Health A Look at What the Future Holds.mp4
Cardiac Amyloidosis A New Era of diagnostics and Therapeutics.mp4
Cardio-obstetrics Maternal Health in Cardiomyopathy Patients.mp4
Cardio-Oncology The Interplay of Immunotherapy, Inflammation, and Cardiomyopathy.mp4
Genetic Testing for Cardiomyopathy.mp4
Interventions to Time to Relax- Novel Therapies for Hypertrophic Cardiomyopathy.mp4
Pulmonary Hypertension Management From Surgical to Medical Therapies.mp4
State of the Art Debate High Risk PCI vs High Risk CABG in Heart Failure PatientsState of the Art Debate High Risk PCI vs High Risk CABG in Heart Failure Patients.mp4
State of the Art Medical Therapies in Advanced Heart Failure What is New in 2023.mp4
State of the Art Therapies Mitral Valve Clip & Minimally Invasive Surgery for Mitral Regurgitation 1.mp4
State of the Art Therapies Mitral Valve Clip & Minimally Invasive Surgery for Mitral Regurgitation 2.mp4
Temporary Percutaneous Support, Durable MCS, and Shared care in the Community.mp4
UCLA Mobile ECMO Updates Managing Shock in the Community.mp4
Working in Sync Device Therapy and Arrhythmia Management.mp4
